Global Biochips
Market report delivers future
development strategies, key companies, Possibility of competition, major
challenges analysis. The reports elaborate the expansion rate of the Biochips
market supported the highest company profile analysis. This report providing an
in-depth analysis, market size, and evaluation for the developing segment among
the Biochips market. Biochips Market report will help you take expert
decisions, recognize opportunities, plan effective professional tactics, plan
new schemes, analyse drivers and restraints and give you a vision on the Biochips
Market forecast.
Industry Insights
Global biochips market size was valued at USD 7.63 billion in 2015. With
potential applications of genomics and proteomics in biotech R&D, along
with rapid technological innovation and increase in adoption of personalized
medicines, it is expected that this market will witness considerable growth in
revnue over the forecast period.
For biochip technology, in order to enhance its usability, there is an
improvement in resolution, preparation procedures and accuracy along with the
reduction in the cost of the materials associated with manufacturing the
biochips. These factors are expected to further reinforce growth potential.
Anticipated commercialization and launch of novel treatments and diagnosis
products including non-laboratory and laboratory research is expected to fuel
growth over the forecast period.
Current developments aiming to miniaturize biochips even further can be
anticipated to increase the additional usage and applicability for genetic
sequencing methodologies, such as diabetes genomics. With the rise in usage of
the biochip technology, it is anticipated that cost of genome profiling can
reduce even further for studies such as protein expression analysis among
others. Hence, proteomics and genomics labeling techniques along with other
protein profiling techniques are expected to witness a growth in demand.
Download Free Sample Report Now @ https://www.millioninsights.com/industry-reports/biochip-market-size/request-sample
Key Questions Answered
·
What are the sales or revenue produced
by Biochips products beyond all sectors during the forecast period?
·
What are the key trends in the Biochips
market?
·
What are the leading drivers, limitations,
and probabilities in the industry?
·
Which segment will gain the
highest revenue worldwide and which product segment will expand at the fastest
CAGR during the forecast period?
·
In which region the Biochips
market to project lucrative CAGR during the forecast period?
End-use Insights
Lab-on-a-chip, cell and tissue array, protein chips and DNA chips find
applications in biotechnology & pharmaceutical companies, research &
academic institutes, hospitals & diagnostics and point of care settings
which involves end users. Protein biochips and LOACs have found widespread use
for single nucleotide polymorphism genotyping, gene expression, in vitro
diagnosis, expression profiling, drug discovery, high throughput screening and
tissue arrays. The commercialization of the products in the development
pipelines of key market participants is also key towards the potential to drive
the growth for the market.
Sophisticated robotic tools are needed for scanning and handling samples
which are in micro-scale. Furthermore, for efficient data analysis efficient
bioinformatics system is required. Therefore, this will increase the need for
specific techniques and system which is expected to increase the demand for
biochips used in sophisticated machines. This will consequently increase the
price of the biochips and widen the offered product range in the market.
Regional Insights
North-America accounted for the largest revenue share owing to the
presence of government policies motivating personalized care for the patients
and availability of proteomics and genetic profiling infrastructure across the
country, especially in the U.S. There has also been a rise in the usage of NGS
(Next Generation Sequencing) for molecular treatment and clinical diagnosis
coupled with microfluidic techniques that add to the large market share.
The Asia Pacific region is expected to grow at the fastest rate during
the forecasted period. Reasons contributing towards the fastest growth in the
market are – increase spending by the government in order to improve healthcare
and R&D infrastructure in the areas of proteomics, genomics and NGS (next
generation sequencing). There has also been growing awareness in the growth
market for early and effective diagnosis which will further increase the growth
in the market.
Competitive Insights
Key players in the development & commercialization of biochips
include PerkinElmer, Inc.; Abbott Laboratories; Bio-Rad Laboratories, Inc.;
Fluidigm Corporation; Sigma-Aldrich Corporation; Agilent Technologies, Inc.;
Thermo Fisher Scientific, Inc. and GE Healthcare. In order to establish
themselves in the untapped market, companies are following various strategies
including mergers & acquisitions, collaboration, vertical and horizontal
integration in regions/countries where they can see potential growth.
For example, PerkinElmer has successfully taken over Vanadis diagnostics
which undergoes cell free DNA-based noninvasive prenatal testing (NIPT) on the
digital platform. This has extended PerkinElmer’s portfolio. Similar strategies
by other companies is expected to influence the market positively which will
also bring competitiveness in the market.
Know
More Insights @ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment